EG19436A - Process for preparing of new xamthine derivatives. - Google Patents

Process for preparing of new xamthine derivatives.

Info

Publication number: EG19436A
Authority: EG; Egypt
Prior art keywords: treating; formamide; excess; compounds; making
Prior art date: 1989-12-27

Application number

EG75090A

Other languages

English (en)

Original Assignee

Almiral S A Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-27

Filing date

1990-12-20

Publication date

1995-02-28

1990-12-20 Application filed by Almiral S A Lab filed Critical Almiral S A Lab

1995-02-28 Application granted granted Critical

1995-02-28 Publication of EG19436A publication Critical patent/EG19436A/xx

Links

238000004519 manufacturing process Methods 0.000 title 1
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 4
150000001875 compounds Chemical class 0.000 abstract 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
239000002585 base Substances 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 abstract 2
-1 methylenedioxy Chemical group 0.000 abstract 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 abstract 2
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 abstract 1
LNDZXOWGUAIUBG-UHFFFAOYSA-N 6-aminouracil Chemical compound NC1=CC(=O)NC(=O)N1 LNDZXOWGUAIUBG-UHFFFAOYSA-N 0.000 abstract 1
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 1
206010002383 Angina Pectoris Diseases 0.000 abstract 1
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
206010019280 Heart failures Diseases 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
208000005314 Multi-Infarct Dementia Diseases 0.000 abstract 1
201000004810 Vascular dementia Diseases 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
230000009286 beneficial effect Effects 0.000 abstract 1
229940124630 bronchodilator Drugs 0.000 abstract 1
239000000168 bronchodilator agent Substances 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
235000019253 formic acid Nutrition 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
150000007530 organic bases Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 abstract 1
229940075931 sodium dithionate Drugs 0.000 abstract 1
235000010288 sodium nitrite Nutrition 0.000 abstract 1
229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
229940124549 vasodilator Drugs 0.000 abstract 1
239000003071 vasodilator agent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Processing Of Stones Or Stones Resemblance Materials (AREA)
Re-Forming, After-Treatment, Cutting And Transporting Of Glass Products (AREA)
Container, Conveyance, Adherence, Positioning, Of Wafer (AREA)
Peptides Or Proteins (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

EG75090A 1989-12-27 1990-12-20 Process for preparing of new xamthine derivatives. EG19436A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898929208A GB8929208D0 (en)	1989-12-27	1989-12-27	New xanthine derivatives

Publications (1)

Publication Number	Publication Date
EG19436A true EG19436A (en)	1995-02-28

Family

ID=10668520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EG75090A EG19436A (en)	1989-12-27	1990-12-20	Process for preparing of new xamthine derivatives.

Country Status (30)

Country	Link
US (1)	US5223504A (pt)
EP (1)	EP0435811B1 (pt)
JP (1)	JPH089617B2 (pt)
KR (1)	KR970001528B1 (pt)
CN (1)	CN1029967C (pt)
AT (1)	ATE93860T1 (pt)
AU (1)	AU635104B2 (pt)
BR (1)	BR9007258A (pt)
CA (1)	CA2045478C (pt)
CZ (1)	CZ278328B6 (pt)
DE (1)	DE69003087T2 (pt)
DK (1)	DK0435811T3 (pt)
EG (1)	EG19436A (pt)
ES (1)	ES2058864T3 (pt)
FI (1)	FI96207C (pt)
GB (1)	GB8929208D0 (pt)
HU (2)	HU208825B (pt)
IE (1)	IE64065B1 (pt)
IL (1)	IL96708A (pt)
MX (1)	MX23884A (pt)
MY (1)	MY105303A (pt)
NO (1)	NO178111C (pt)
NZ (1)	NZ236517A (pt)
PL (1)	PL166152B1 (pt)
PT (1)	PT96332B (pt)
RU (1)	RU2073679C1 (pt)
SK (1)	SK278365B6 (pt)
UA (1)	UA32512C2 (pt)
WO (1)	WO1991009859A1 (pt)
ZA (1)	ZA9010240B (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9203323A (es) *	1991-07-11	1994-07-29	Hoechst Ag	El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
US5521315A (en) *	1993-01-12	1996-05-28	Cell Therapeutics, Inc.	Olefin substituted long chain compounds
GB9312853D0 (en)	1993-06-22	1993-08-04	Euro Celtique Sa	Chemical compounds
US5591776A (en)	1994-06-24	1997-01-07	Euro-Celtique, S.A.	Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5922751A (en)	1994-06-24	1999-07-13	Euro-Celtique, S.A.	Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5661153A (en) *	1994-07-19	1997-08-26	Japan Energy Corporation	1-arylpyrimidine derivatives and pharmaceutical use thereof
CA2206804C (en) *	1994-12-13	2002-03-19	Euro-Celtique, S.A.	Trisubstituted thioxanthines
JPH10508032A (ja) *	1994-12-13	1998-08-04	ユーロ−セルティーク，エス．エイ．	アリールチオキサンチン類
US6025361A (en) *	1994-12-13	2000-02-15	Euro-Celtique, S.A.	Trisubstituted thioxanthines
US5821366A (en) *	1995-05-19	1998-10-13	Chiroscience Limited	Xanthines and their therapeutic use
US6166041A (en)	1995-10-11	2000-12-26	Euro-Celtique, S.A.	2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en)	1996-04-10	2000-06-13	Euro-Celtique S.A.	6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en)	1996-06-06	1999-01-26	Euro-Celtique, S.A.	Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
WO1998019672A1 (en) *	1996-11-01	1998-05-14	Nitromed Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
USRE37234E1 (en) *	1996-11-01	2001-06-19	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses
US5874437A (en) *	1996-11-01	1999-02-23	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6331543B1 (en) *	1996-11-01	2001-12-18	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
US5958926A (en) *	1996-11-01	1999-09-28	Nitromed, Inc.	Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
GB9623859D0 (en) *	1996-11-15	1997-01-08	Chiroscience Ltd	Novel compounds
US6472425B1 (en)	1997-10-31	2002-10-29	Nitromed, Inc.	Methods for treating female sexual dysfunctions
IL132407A0 (en) *	1998-10-21	2001-03-19	Pfizer Prod Inc	Method for treating congestive heart failure
ES2228512T3 (es) *	1999-05-04	2005-04-16	Altana Pharma Ag	Combinacion sinergica que comprende roflumilast y un inhibidor de pde-3.
SK287231B6 (sk)	1999-08-21	2010-04-07	Nycomed Gmbh	Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
GB0005199D0 (en) *	2000-03-04	2000-04-26	Imp College Innovations Ltd	Modulation of histone deacetylase
EP1265861A2 (en) *	2000-03-16	2002-12-18	Inflazyme Pharmaceuticals, Ltd.	Benzylated pde4 inhibitors
JP4510383B2 (ja) *	2001-05-23	2010-07-21	田辺三菱製薬株式会社	軟骨疾患修復治療用組成物
WO2002094321A1 (en) *	2001-05-23	2002-11-28	Tanabe Seiyaku Co., Ltd.	Compositions for promoting healing of bone fracture
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
AU2004226353A1 (en)	2003-04-01	2004-10-14	Laboratoires Serono Sa	Inhibitors of phosphodiesterases in infertility
RU2395511C2 (ru) *	2004-02-14	2010-07-27	Смитклайн Бичам Корпорейшн	Новые соединения
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en)	2008-06-04	2010-05-13	Synergy Pharmaceuticals, Inc.	Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
AU2008261102B2 (en)	2007-06-04	2013-11-28	Bausch Health Ireland Limited	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es)	2008-07-16	2017-07-17	Synergy Pharmaceuticals Inc.	Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
KR102034748B1 (ko)	2011-03-01	2019-10-21	시너지 파마슈티컬즈 인코포레이티드	구아닐레이트 사이클라제 c 작용제의 제조 방법
US9545446B2 (en)	2013-02-25	2017-01-17	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
HK1220611A1 (zh)	2013-03-15	2017-05-12	Bausch Health Ireland Limited	用於治疗胃肠道病症的组成物
US9708367B2 (en)	2013-03-15	2017-07-18	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
EP3004138B1 (en)	2013-06-05	2024-03-13	Bausch Health Ireland Limited	Ultra-pure agonists of guanylate cyclase c, method of making and using same
JP6694385B2 (ja)	2013-08-09	2020-05-13	アーデリクス，インコーポレーテッド	リン酸塩輸送阻害のための化合物及び方法
EP3165224A1 (en)	2015-11-09	2017-05-10	Albert-Ludwigs-Universität Freiburg	Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
WO2017089347A1 (en)	2015-11-25	2017-06-01	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas
AR115689A1 (es)	2018-07-05	2021-02-17	Sumitomo Chemical Co	Compuestos de uracilo y su utilización
CN114340631A (zh)	2019-05-21	2022-04-12	阿德利克斯股份有限公司	用于降低患者的血清磷酸盐的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1245969B (de) *		1967-08-03	VEB Arzneimittelwerk Dresden, Radebeul	Verfahren zur Herstellung von Xanthinderivaten
CH629788A5 (de) *	1977-07-20	1982-05-14	Lonza Ag	Verfahren zur herstellung von 5,6-diaminouracil.
SE416810C (sv) *	1977-10-14	1982-07-19	Draco Ab	Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
GB8826595D0 (en) *	1988-11-14	1988-12-21	Beecham Wuelfing Gmbh & Co Kg	Active compounds

1989
- 1989-12-27 GB GB898929208A patent/GB8929208D0/en active Pending
1990
- 1990-12-18 IL IL9670890A patent/IL96708A/en not_active IP Right Cessation
- 1990-12-18 CZ CS906341A patent/CZ278328B6/cs not_active IP Right Cessation
- 1990-12-18 SK SK6341-90A patent/SK278365B6/sk unknown
- 1990-12-18 NZ NZ236517A patent/NZ236517A/xx unknown
- 1990-12-19 AT AT90500126T patent/ATE93860T1/de not_active IP Right Cessation
- 1990-12-19 DK DK90500126.9T patent/DK0435811T3/da active
- 1990-12-19 ES ES90500126T patent/ES2058864T3/es not_active Expired - Lifetime
- 1990-12-19 EP EP90500126A patent/EP0435811B1/en not_active Expired - Lifetime
- 1990-12-19 ZA ZA9010240A patent/ZA9010240B/xx unknown
- 1990-12-19 DE DE90500126T patent/DE69003087T2/de not_active Expired - Fee Related
- 1990-12-20 IE IE463490A patent/IE64065B1/en not_active IP Right Cessation
- 1990-12-20 EG EG75090A patent/EG19436A/xx active
- 1990-12-21 MY MYPI90002243A patent/MY105303A/en unknown
- 1990-12-21 CN CN90110056A patent/CN1029967C/zh not_active Expired - Fee Related
- 1990-12-21 MX MX2388490A patent/MX23884A/es unknown
- 1990-12-21 PT PT96332A patent/PT96332B/pt not_active IP Right Cessation
- 1990-12-27 KR KR1019910700878A patent/KR970001528B1/ko not_active Expired - Fee Related
- 1990-12-27 CA CA002045478A patent/CA2045478C/en not_active Expired - Fee Related
- 1990-12-27 HU HU912782A patent/HU208825B/hu not_active IP Right Cessation
- 1990-12-27 UA UA5001584A patent/UA32512C2/uk unknown
- 1990-12-27 US US07/743,388 patent/US5223504A/en not_active Expired - Lifetime
- 1990-12-27 JP JP3501868A patent/JPH089617B2/ja not_active Expired - Fee Related
- 1990-12-27 RU SU905001584A patent/RU2073679C1/ru not_active IP Right Cessation
- 1990-12-27 BR BR909007258A patent/BR9007258A/pt not_active Application Discontinuation
- 1990-12-27 AU AU69768/91A patent/AU635104B2/en not_active Ceased
- 1990-12-27 WO PCT/GB1990/002027 patent/WO1991009859A1/en not_active Ceased
- 1990-12-27 PL PL90292006A patent/PL166152B1/pl not_active IP Right Cessation
1991
- 1991-08-19 NO NO913236A patent/NO178111C/no unknown
- 1991-08-26 FI FI914014A patent/FI96207C/fi active
1995
- 1995-06-30 HU HU95P/P00698P patent/HU211573A9/hu unknown

Also Published As

Publication number	Publication date
IL96708A0 (en)	1991-09-16
JPH089617B2 (ja)	1996-01-31
HU211573A9 (en)	1995-12-28
ATE93860T1 (de)	1993-09-15
NO178111B (no)	1995-10-16
FI96207B (fi)	1996-02-15
GB8929208D0 (en)	1990-02-28
AU6976891A (en)	1991-07-24
NO913236L (no)	1991-08-19
IL96708A (en)	1994-06-24
MX23884A (es)	1993-09-01
NO178111C (no)	1996-01-24
HU208825B (en)	1994-01-28
KR920701207A (ko)	1992-08-11
EP0435811A1 (en)	1991-07-03
IE904634A1 (en)	1991-07-17
CN1029967C (zh)	1995-10-11
ES2058864T3 (es)	1994-11-01
DK0435811T3 (da)	1993-11-01
EP0435811B1 (en)	1993-09-01
SK278365B6 (en)	1997-01-08
WO1991009859A1 (en)	1991-07-11
HUT57766A (en)	1991-12-30
BR9007258A (pt)	1992-02-25
KR970001528B1 (ko)	1997-02-11
CA2045478C (en)	1998-12-29
JPH05500226A (ja)	1993-01-21
IE64065B1 (en)	1995-07-12
PT96332A (pt)	1991-09-30
FI96207C (fi)	1996-05-27
FI914014A0 (fi)	1991-08-26
CZ278328B6 (en)	1993-11-17
PL166152B1 (en)	1995-04-28
NO913236D0 (no)	1991-08-19
PT96332B (pt)	1998-06-30
MY105303A (en)	1994-09-30
NZ236517A (en)	1992-09-25
US5223504A (en)	1993-06-29
UA32512C2 (uk)	2001-02-15
AU635104B2 (en)	1993-03-11
RU2073679C1 (ru)	1997-02-20
CN1052858A (zh)	1991-07-10
DE69003087D1 (de)	1993-10-07
DE69003087T2 (de)	1993-12-16
CA2045478A1 (en)	1991-06-28
ZA9010240B (en)	1991-10-30

Publication	Publication Date	Title
EG19436A (en)	1995-02-28	Process for preparing of new xamthine derivatives.
ZA911441B (en)	1991-11-27	Aryl-and heteroarylethenylene derivatives and process for their preparation
HU912676D0 (en)	1992-01-28	Sulfonamide derivatives
TW377352B (en)	1999-12-21	Pyrido[2,3-d]pyrimidine derivatives and pharmaceutical compositions thereof
HUT53099A (en)	1990-09-28	Process for producing new tetrahydrobenzimidazole derivatives and pharmaceutical compositions comprising such compounds
ES8702911A1 (es)	1987-01-16	Un procedimiento para la preparacion de nuevos derivados de guanina.
ES8504800A1 (es)	1985-05-01	Procedimiento para preparar derivados de 1, 6-naftiridinona
GB8427125D0 (en)	1984-12-05	Organic compounds
ES8700857A1 (es)	1986-11-16	Un procedimiento para la produccion de dihidropiridinas
ES8706610A1 (es)	1987-07-01	Proceso para preparar un derivado de aminoalcohol.
ES8606847A1 (es)	1986-05-16	Procedimiento para la preparacion de derivados de dialquila-mino-etilanilina antihipertensos
ES8306733A1 (es)	1983-06-01	Derivados de anilina y sus sales.
HUT40793A (en)	1987-02-27	Process for preparing hexene-carboxylic acid derivatives
DE68928127D1 (de)	1997-07-17	2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
IE893171L (en)	1990-04-05	Aryloxy-, arylthio-, heteroaryloxy-,¹heteroarylthio-alkenylene derivatives of amines
DK143403B (da)	1981-08-17	Analogifremgangsmaade til fremstilling af 8-(1h-tetrazol-5-yl)-11h-pyrido (2,1-b) quinazolin-11-oner eller salte deraf
IT1231425B (it)	1991-12-04	Procedimento per la sintesi di un derivato dell'acido benzo (ij) chinolizin-2-carbossilico
HUT47938A (en)	1989-04-28	Process for producing indoloquinoxaline derivatives with substituent in 6-position containing cyclic group, as well as pharmaceuticals comprising these compounds as active ingredient
MY104630A (en)	1994-04-30	4(1h) ouinoline derivatives
ES8802296A1 (es)	1987-04-16	Un metodo para preparar un derivado de acido benzoico